|
1
|
Shen DF, Chang MA, Matteson DM, Buggage R,
Kozhich AT and Chan CC: Biphasic ocular inflammatory response to
endotoxin-induced uveitis in mouse. Arch Ophthalmol. 118:521–527.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Joussen AM, Poulaki V, Le M, et al: A
central role for inflammation in the pathogenesis of diabetic
retinopathy. FASEB J. 18:1450–1452. 2004.PubMed/NCBI
|
|
3
|
Rodrigues EB: Inflammation in dry
age-related macular degeneration. Ophthalmologica. 221:143–152.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Strauss O: The retinal pigment epithelium
in visual function. Physiol Rev. 85:845–881. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumaki N, Anderson DM, Cosman D and Kumaki
S: Expression of interleukin-15 and its receptor by human fetal
retinal pigment epithelial cells. Curr Eye Res. 15:876–882. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McLaren MJ: Kinetics of rod outer segment
phagocytosis by cultured retinal pigment epithelial cells.
Relationship to cell morphology. Invest Ophthalmol Vis Sci.
37:1213–1224. 1996.PubMed/NCBI
|
|
7
|
Yu FS and Hazlett LD: Toll-like receptors
and the eye. Invest Ophthalmol Vis Sci. 47:1255–1263. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ishii S and Shimizu T: Platelet-activating
factor (PAF) receptor and genetically engineered PAF receptor
mutant mice. Prog Lipid Res. 39:41–82. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han SJ, Choi JH, Ko HM, et al:
Glucocorticoids prevent NF-kappaB activation by inhibiting the
early release of platelet-activating factor in response to
lipopolysaccharide. Eur J Immunol. 29:1334–1341. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Camussi G, Tetta C and Baglioni C: The
role of platelet activating factor in inflammation. Clin Immun
Immunopathol. 57:331–338. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lotner GZ, Lynch JM, Betz SJ and Henson
PM: Human neutrophil-derived platelet activating factor. J Immunol.
124:676–684. 1980.PubMed/NCBI
|
|
12
|
Triggiani M, Schleimer RP, Warner JA and
Chilton FH: Differential synthesis of
1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating
factor by human inflammatory cells. J Immunol. 147:660–666.
1991.PubMed/NCBI
|
|
13
|
Sumita C, Maeda M, Fujio Y, et al:
Pioglitazone induces plasma platelet activating
factor-acetylhydrolase and inhibits platelet activating
factor-mediated cytoskeletal reorganization in macrophage. Biochim
Biophys Acta. 1673:115–121. 2004. View Article : Google Scholar
|
|
14
|
Tjoelker LW, Wilder C, Eberhardt C, et al:
Anti-inflammatory properties of a platelet-activating factor
acetylhydrolase. Nature. 374:549–553. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tontonoz P, Nagy L, Alvarez JG, Thomazy VA
and Evans RM: PPARγ promotes monocyte/macrophage differentiation
and uptake of oxidized LDL. Cell. 93:241–252. 1998.
|
|
16
|
Mueller E, Sarraf P, Tontonoz P, et al:
Terminal differentiation of human breast cancer through PPARγ. Mol
Cell. 1:465–470. 1998.
|
|
17
|
Buckingham RE: Thiazolidinediones:
pleiotropic drugs with potent anti-inflammatory properties for
tissue protection. Hepatol Res. 33:167–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Consoli A and Devangelio E:
Thiazolidinediones and inflammation. Lupus. 14:794–797. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Drew PD and Chavis JA: The cyclopentone
prostaglandin 15-deoxy-δ12,14 prostaglandin
J2 represses nitric oxide, TNF-, and IL-12 production by
microglial cells. J Neuroimmunol. 115:28–35. 2001.
|
|
20
|
Garg TK and Chang JY: Oxidative stress
causes ERK phosphorylation and cell death in cultured retinal
pigment epithelium: prevention of cell death by AG126 and
15-deoxy-delta12,14-PGJ2. BMC Ophthalmol.
3:52003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Surh YJ, Na HK, Park JM, et al:
15-Deoxy-Δ12,14-prostaglandin J2, an
electrophilic lipid mediator of anti-inflammatory and pro-resolving
signaling. Biochem Pharmacol. 82:1335–1351. 2011.
|
|
22
|
Abdelrahman M, Sivarajah A and Thiemermann
C: Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion
injury, inflammation and shock. Cardiovasc Res. 65:772–781. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosenbaum JT, Angell E, Wilson D, Broquet
C, Boney RS and Braquet P: Intravitreally injected platelet
activating factor induces retinitis in experimental animals. Curr
Eye Res. 18:342–348. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bulger EM, Arbabi S, Garcia I and Maier
RV: The macrophage response to endotoxin requires platelet
activating factor. Shock. 17:173–179. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cousin SW, Guss RB, Howes EL Jr and
Rosenbaum JT: Endotoxin-induced uveitis in the rat: observations on
alters vascular permeability, clinical findings and histology. Exp
Eye Res. 35:665–676. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki M, Noda K, Kubota S, et al:
Eicosapentaenoic acid suppresses ocular inflammation in
endotoxin-induced uveitis. Mol Vis. 16:1382–1388. 2010.PubMed/NCBI
|
|
27
|
Leung KW, Barnstable CJ and Tombran-Tink
J: Bacterial endotoxin activates retinal pigment epithelial cells
and induces their degeneration through IL-6 and IL-8 autocrine
signaling. Mol Immunol. 46:1374–1386. 2009. View Article : Google Scholar
|
|
28
|
Planck SR, Dang TT, Graves D, Tara D,
Ansel JC and Rosenbaum JT: Retinal pigment epithelial cells secrete
interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis
Sci. 33:78–82. 1992.PubMed/NCBI
|
|
29
|
Feghali CA and Wright TM: Cytokines in
acute and chronic inflammation. Front Biosci. 2:d12–d26.
1997.PubMed/NCBI
|
|
30
|
Biswas PS, Banerjee K, Kinchington PR and
Rouse BT: Involvement of IL-6 in the paracrine production of VEGF
in ocular HSV-1 infection. Exp Eye Res. 82:46–54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
De Vos AF, Hoekzema R and Kijlstra A:
Cytokines and uveitis, a review. Curr Eye Res. 11:581–597.
1992.PubMed/NCBI
|
|
32
|
Verma MJ, Lloyd A, Rager H, et al:
Chemokines in acute anterior uveitis. Curr Eye Res. 16:1202–1208.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakazawa T, Hisatomi T, Nakazawa C, et al:
Monocyte chemoattractant protein 1 mediates retinal
detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci USA.
104:2425–2430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kanagawa T, Matsuda S, Mikawa Y, et al:
Role of ICAM-1 and LFA-1 in endotoxin-induced uveitis in mice. Jpn
J Ophthalmol. 40:174–180. 1996.PubMed/NCBI
|
|
35
|
Tsuji F and Shirasawa E: The role of
platelet-activating factor in cell infiltration in
endotoxin-induced uveitis in guinea pigs. Curr Eye Res. 17:501–505.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang JZ, Cavet ME, VanderMeid KR,
Salvador-Silva M, López FJ and Ward KW: BOL-303242-X, a novel
selective glucocorticoid receptor agonist, with full
anti-inflammatory properties in human ocular cells. Mol Vis.
15:2606–2616. 2009.PubMed/NCBI
|
|
37
|
Rodrigues CE, Sanches TR, Volpini RA, et
al: Effects of continuous erythropoietin receptor activator in
sepsis-induced acute kidney injury and multi-organ dysfunction.
PLoS One. 7:e298932012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Straus DS, Pascual G, Li M, et al:
15-deoxy-delta12,14-prostaglandin J2 inhibits
multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad
Sci USA. 97:4844–4849. 2000.PubMed/NCBI
|
|
39
|
Inoue H, Tanabe T and Umeson K: Feedback
control of cyclooxygenase-2 expression through PPARgamma. J Biol
Chem. 275:28028–28032. 2000.PubMed/NCBI
|
|
40
|
Thieringer R, Fenyk-Melody JE, Le Grand
CB, et al: Activation of peroxisome proliferator-activated receptor
gamma does not inhibit IL-6 or TNF-alpha responses of macrophages
to lipopolysaccharide in vitro or in vivo. J Immunol.
164:1046–1054. 2000. View Article : Google Scholar : PubMed/NCBI
|
